These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 27535187)
61. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Baker WL; White WB Ann Pharmacother; 2011 Dec; 45(12):1506-15. PubMed ID: 22116996 [TBL] [Abstract][Full Text] [Related]
62. Insights into Chronic Lithium Toxicity - A Case Report. Varghese GS; Rajachandran K; Murugesan I Curr Drug Saf; 2023; 18(1):112-115. PubMed ID: 35431000 [TBL] [Abstract][Full Text] [Related]
63. [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. Gille M; Ghariani S; Piéret F; Delbecq J; Depré A; Saussu F; de Barsy T Rev Neurol (Paris); 1997 May; 153(4):268-70. PubMed ID: 9296146 [TBL] [Abstract][Full Text] [Related]
65. Stabilization of the Serum Lithium Concentration by Regulation of Sodium Chloride Intake: Case Report. Tomita T; Goto H; Sumiya K; Yoshida T; Tanaka K; Kohda Y Yakugaku Zasshi; 2016; 136(3):517-21. PubMed ID: 26935095 [TBL] [Abstract][Full Text] [Related]
66. Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment. Dudkowski C; Karim A; Zhao Z; Alonso AB; Garg D; Preston RA J Clin Pharmacol; 2018 Jan; 58(1):48-56. PubMed ID: 28750149 [TBL] [Abstract][Full Text] [Related]
67. Acute renal failure induced by markedly decreased appetite secondary to a depressive episode after discontinuation of long-term lithium therapy in an elderly patient with bipolar disorder. Okada A BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24835805 [TBL] [Abstract][Full Text] [Related]
68. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901 [TBL] [Abstract][Full Text] [Related]
69. Cyclic 48-hour unipolar depression. Zisook S J Nerv Ment Dis; 1988 Jan; 176(1):53-6. PubMed ID: 3121783 [TBL] [Abstract][Full Text] [Related]
70. Lithium neurotoxicity. Suraya Y; Yoong KY Med J Malaysia; 2001 Sep; 56(3):378-81. PubMed ID: 11732087 [TBL] [Abstract][Full Text] [Related]
75. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139 [TBL] [Abstract][Full Text] [Related]
76. Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor. Masiran R; Abdul Aziz MF BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28847993 [TBL] [Abstract][Full Text] [Related]
77. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Normann C; Brandt C; Berger M; Walden J Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353 [TBL] [Abstract][Full Text] [Related]
78. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216 [TBL] [Abstract][Full Text] [Related]
79. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. Ketter TA J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635 [TBL] [Abstract][Full Text] [Related]